[1] |
Bischoff J. Endothelial-to-mesenchymal transition[J]. Circ Res, 2019, 124:1163-1165. doi: 10.1161/CIRCRESAHA.119.314813.
|
[2] |
黄云,许喜生,陈凯,等.下调lncRNA-H19表达促进人瘢痕疙瘩成纤维细胞凋亡和自噬[J].基础医学与临床, 2022, 42: 633-639. doi:10.16352/j.issn.1001-6325.2022.04.023.
|
[3] |
Wang ZH, Wang JH, Wang KQ, et al. LncRNA FEZF1-AS1 promoted chemoresistance, autophagy and epithelial-mesenchymal transition (EMT) through regulation of miR-25-3p/ITGB8 axis in prostate cancer[J]. Eur Rev Med Pharmacol Sci, 2020, 24:8250. doi: 10.26355. /eurrev_202008_22591.
|
[4] |
Zhou C, Jiang X, Liang A, et al. LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma[J]. Neurosci Lett, 2021, 764:136245. doi: 10.1016/j.neulet.2021.136245.
|
[5] |
Heward JA, Lindsay MA, Long non-coding RNAs in the regulation of the immune response[J]. Trends Immunol, 2014, 35:408-419. doi: 10.1016/j.it.2014.07.005.
|
[6] |
Prensner JR, Iyer MK, Sahu A, et al. The long noncod-ing RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex[J]. Nat Genet, 2013, 45:1392-1398. doi: 10.1038/ng.2771.
|
[7] |
Zhang J, Wang H, Chen H, et al. ATF3-activated accelerating effect of LINC00941/LncIAPF on fibroblast-to-myofibroblast differentiation by blocking autophagy depending on ELAVL1/HuR in pulmonary fibrosis[J]. Autophagy, 2022, 18:2636-2655. doi: 10.1080/15548627.2022.2046448.
|
[8] |
Chen T, Guo Y, Wang J, et al. LncRNA CTD-2528L19.6 prevents the progression of IPF by alleviating fibroblast activation[J]. Cell Death Dis, 2021, 12:600. doi: 10.1038/s41419-021-03884-5.
|
[9] |
Wang Y, Chen D, Xie H, et al. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter [J]. Mol Med, 2023, 29:32. doi: 10.1186/s10020-023-00620-x.
|
[10] |
Liu P, Zhao L, Gu Y, et al. LncRNA SNHG16 promotes pulmonary fibrosis by targeting miR-455-3p to regulate the Notch2 pathway[J]. Respir Res, 2021, 22:44. doi: 10.1186/s12931-021-01632-z.
|
[11] |
Wang YD, Sun XJ, Yin JJ, et al. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma[J]. Biomed Pharmacother,2018, 106:134-141. doi: 10.1016/j.biopha.2018.05.116.
|
[12] |
Sun J, Jin T, Niu Z, et al. LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation[J]. Acta Pharm Sin B, 2022, 12:3602-3617. doi: 10.1016/j.apsb.2022.04.006.
|
[13] |
Qi F, Lv ZD, Huang WD, et al. LncRNA TUG1 promotes pulmonary fibrosis progression via up-regulating CDC27 and activating PI3K/Akt/mTOR pathway[J]. Epigenetics, 2023, 18:2195305. doi: 10.1080/15592294.2023.2195305.
|